missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

INSR Recombinant Human Protein (Long Isoform, without Catalytic Activity Domain), His Tag, Invitrogen™ Sino Biological™ DFS Item

This recombinant protein was expressed from a DNA sequence encoding the extracellular domain (Met 1-Lys 956) of human INSR long isoform (NP_000199.2) fused to a polyhistidine tag at the C-terminus

$314.00 - $314.00

Specifications

Purity ≥85% by SDS-PAGE
Endotoxin Concentration <1 EU/μg
Format Lyophilized
Gene Alias CD220, HHF5, INSR
Gene ID (Entrez) 3643
View More Specs

Products 1
Catalog Number Mfr. No. Quantity Price Quantity  
Catalog Number Mfr. No. Quantity Price Quantity  
11081H08H50 View Documents Life Technologies
LS11081H08H50
50μg Each for $314.00
 
Description

Description

Insulin receptor (INSR), recombinant human protein is supplied as a lyophilized powder. It is suitable for use in protein studies such as protein structure analysis and protein-protein interactions. In general, recombinant proteins can also be used as an immunogen, as a protein standard, or in cell biology research applications. Since this product is a truncated protein and does not contain intracellular catalytic activity domain, it is not suitable for use in enzyme activity studies.
  • Activity: Measured by its binding ability in a functional ELISA; when 1μg/mL of biotinylated human insulin is immobilized onto a streptavidin coated plate, it can bind human INSR, isoform long, with a linear range of 0.625-10μg/mL
  • Formulation: Lyophilized in PBS, pH 7.4, 5% Mannitol, 5% Trehalose, and 0.02% Tween-80
  • Reconstitution: Dissolve the protein in sterile double distilled water to a concentration of 0.2mg/mL or lower; aliquot and use as soon as possible

Shipping Condition: Room Temperature. This protein is manufactured by Sino Biological Inc.

Specifications

Specifications

≥85% by SDS-PAGE
Lyophilized
3643
<1 EU/μg
CD220, HHF5, INSR

For Research Use Only. Not for use in diagnostic procedures.